Partisan Healthcare Advisory takes Healthcare companies from clinical study to commercial scale across every major geography — accelerating time to market while cutting cost, so innovations that benefit millions actually reach them.
Partisan Healthcare Advisory LLC is an Irvine, California based management consulting firm focused on healthcare commercial-channel development, clinical studies, and supply-chain optimization.
We help healthcare companies accelerate time to market while reducing overall cost. That often starts with high-speed, low-cost clinical studies paired with the right supply-chain partner — and extends through local regulatory approvals and a purpose-built commercial channel in every major market.
Our leadership has run cardiology for Baxter in Japan, all of Asia for Edwards Lifesciences, and taken multiple startups from inception to full global launch. On the ground in India, we operate through our majority-owned company, Indical MedSurg — giving clients a direct clinical and commercial organization, not a chain of subcontractors.
See what we do →Everything a healthcare company needs to reach and scale a new market — a product's actual route from first study to first sale, handled end to end.
A full clinical organization to run device trials fast and affordably — from First-in-Human through pivotal and registry studies, structured to support both regulatory approval and commercial adoption.
Choosing the right contract manufacturer reshapes your economics — lowering cost of goods, capital outlay, import tariffs, and time to market. We manage transfer, validation, and second-source setup end to end.
Regional sales-channel managers in every major market build the go-to-market that fits your product — direct sales force, distribution network, or hybrid — then run it or hand it over.
The innovations we back are among the most inventive in healthcare. Names are withheld at our partners' request — the work speaks for itself.
The challenge. A UK-based surgical-robotics company needed a trusted partner to navigate regulatory approvals, stand up a local legal entity, run a first-in-human robotic surgery evaluation, and open a commercial pathway across the Asia–Middle East–Africa region — all against a tight clock.
What we did. Through our India organization, Indical, we acted as the on-the-ground Authorised Representative, managed every regulatory submission, established the client's local entity, coordinated the first-in-human evaluation across top surgical centers, and activated the AMEA commercial distribution channel.
The challenge. A structural-heart innovator had developed a polymer heart valve with the potential to reach the millions of patients who can't tolerate today's tissue or mechanical options — and needed a fast, rigorous clinical pathway to prove it and open the route to first commercial approval.
What we did. Operating the innovator's own India entity, our India organization, Indical, ran the polymer heart-valve clinical study end to end — leading clinical operations and coordinating leading cardiac centers — supporting the path to the world's first commercially available polymer heart valve.
A sample of the categories we've supported across clinical, regulatory, manufacturing, and commercial workstreams.
The people who will run your program have built channels, transferred manufacturing, and launched devices across the world.
41 years in high tech, the last 25 as a medical-device CEO. Ran cardiology for Baxter CVG in Japan and all of Asia for Edwards Lifesciences, and brought two startups from inception to full global launch. Degree in applied physics; speaks Spanish, Korean, and Japanese. Based in Irvine, CA.
41 years of pharma and medical-device commercialization. Has built distribution networks in every major market — including the US — and multiple direct sales forces in India. A recognized expert in establishing commercial channels across South Asia and Africa–ME. Based in Mumbai, India.
Biomedical engineer with deep experience in design, design-for-manufacturing, overseas manufacturing transfer, and value engineering. Former VP of R&D at Integrated Endoscopy, where he led transfers to China, Taiwan, India, and the DR. Heads the global technical function. Based in Irvine, CA.
15+ years in clinical research and global operations. Former Global VP of Clinical & Operations at Integrated Endoscopy and India Clinical Manager at Foldax, with a strong record building clinical, regulatory, and operations teams across therapeutic areas. Core expertise in India and Africa–ME. Based in Pune, India.
15+ years in accounting, financial management, and corporate administration in the medical-device sector. Leads finance and corporate operations at Indical — foreign-investment and ECB structuring, statutory compliance, and commercial finance for market entrants — with prior roles at Insightra Medical and CMR Surgical. B.Com in Accountancy; MBA in Corporate Finance. Based in Goa, India.
Leads regulatory affairs, quality assurance, and manufacturing at Indical. Manages CDSCO and MD-15 submissions, quality-management systems, and the local production and sterilization partnerships behind device manufacturing and import in India. Based in India.
A guide, not a rulebook — we adapt each step to your product, timeline, and commercial goals.
We learn your product, therapy area, target markets, and commercial goals.
A tailored market-entry plan: regulatory route, clinical strategy, and channel model.
NDA and service agreement executed — scope, timelines, and terms agreed.
We prepare and file applications with the relevant health authorities.
Where required, our clinical organization runs trials or registry studies.
Approval secured, distribution activated, first sales and ongoing support.
Beyond in-house resources, we activate specialist partners by region and need — anchored by our own India organization.
Our on-the-ground organization in India and the single-window partner for healthcare companies entering the region. Indical combines a full-service CRO, regulatory representation, local manufacturing, and pan-India distribution under one roof — so clients get a direct clinical and commercial team, not a chain of subcontractors.
Visit Indical ↗US FDA-registered, ISO-certified manufacturing partner in Gujarat's device cluster — ETO sterilization and ISO Class 7 cleanroom production, with duty-free import/export pathways and up to 50% cost reduction.
CMO partners across the US, Japan, China, Singapore/Malaysia, Thailand, India, Brazil, Mexico, and the Dominican Republic.
Specialist regulatory partners spanning 50+ countries to secure approvals and unlock revenue in each target market.
Distribution partners in every region across a wide range of clinical indications, plus HR and fractional-management partners in major markets.
Tell us about your device and where you want to take it. We'll come back with a candid view of the pathway, timeline, and cost.